47 results
8-K
EX-10.1
SABS
SAB Biotherapeutics, Inc.
31 Jul 24
SAB BIO Appoints Lucy To as Chief Financial Officer
8:00am
8-K
EX-10.1
SABS
SAB Biotherapeutics, Inc.
30 May 24
SAB Biotherapeutics Announces Departure of Chief Financial Officer
6:49pm
8-K
EX-10.1
SABS
SAB Biotherapeutics, Inc.
8 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.2
SABS
SAB Biotherapeutics, Inc.
8 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
dfbi9y0bvtmp44gu
27 Oct 23
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
ioequpjk8nwfb ezpv
2 Oct 23
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
4:10pm
8-K
EX-10.1
tlyeqhij
12 Dec 22
SAB Biotherapeutics Announces $7.9 Million Private Placement of Common Stock
9:07am
8-K
EX-10.2
w0f2ys3np7
1 Nov 22
SAB Biotherapeutics Announces Exclusive Manufacturing Partnership
5:06pm
8-K
EX-10.1
14c6fky
1 Nov 22
SAB Biotherapeutics Announces Exclusive Manufacturing Partnership
5:06pm
8-K
EX-10.1
lasaef
13 Oct 22
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.1
znrdyhvlwa gp
19 Nov 21
Entry into a Material Definitive Agreement
4:49pm
8-K
EX-10.3
dbx94
28 Oct 21
Entry into a Material Definitive Agreement
5:16pm
8-K
EX-10.4
k238x
28 Oct 21
Entry into a Material Definitive Agreement
5:16pm
8-K
EX-10.5
za66 bd38ax6
28 Oct 21
Entry into a Material Definitive Agreement
5:16pm